These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 33125126)
1. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review). He R; Du S; Lei T; Xie X; Wang Y Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126 [TBL] [Abstract][Full Text] [Related]
2. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749 [TBL] [Abstract][Full Text] [Related]
3. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373 [TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses. Sahin I; Eturi A; De Souza A; Pamarthy S; Tavora F; Giles FJ; Carneiro BA Cancer Biol Ther; 2019; 20(8):1047-1056. PubMed ID: 30975030 [TBL] [Abstract][Full Text] [Related]
5. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer. Lin J; Song T; Li C; Mao W Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118659. PubMed ID: 31978503 [TBL] [Abstract][Full Text] [Related]
6. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder. Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064 [TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19 Li J; Gao J; Zhou H; Zhou J; Deng Z; Lu Y; Rao J; Ji G; Gu J; Yang X; Xia Y; Wang X Front Immunol; 2020; 11():603288. PubMed ID: 33343576 [TBL] [Abstract][Full Text] [Related]
9. The role of glycogen synthase kinase 3 beta in multiple sclerosis. Noori T; Dehpour AR; Sureda A; Fakhri S; Sobarzo-Sanchez E; Farzaei MH; Küpeli Akkol E; Khodarahmi Z; Hosseini SZ; Alavi SD; Shirooie S Biomed Pharmacother; 2020 Dec; 132():110874. PubMed ID: 33080467 [TBL] [Abstract][Full Text] [Related]
10. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model. Darshit BS; Ramanathan M Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108 [TBL] [Abstract][Full Text] [Related]
11. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer. Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024 [TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis. Zheng H; Yang Z; Xin Z; Yang Y; Yu Y; Cui J; Liu H; Chen F Theranostics; 2020; 10(25):11737-11753. PubMed ID: 33052244 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Yoshino Y; Ishioka C Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722 [TBL] [Abstract][Full Text] [Related]